Involvement of UBE1L in ISG15 conjugation during retinoid-induced differentiation of acute promyelocytic leukemia.
D002454:Cell Differentiation / Q000187:drug effects; D045744:Cell Line, Tumor; D016207:Cytokines / Q000378:metabolism*; D015973:Gene Expression Regulation, Leukemic / Q000187:drug effects*; D006801:Humans; D007372:Interferons / Q000494:pharmacology; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy / Q000473:pathology*; D012333:RNA, Messenger / Q000032:analysis; D034741:RNA, Small Interfering / Q000494:pharmacology; D014018:Tissue Distribution; D014212:Tretinoin / Q000494:pharmacology*; D025521:Tumor Suppressor Proteins / Q000502:physiology; D025801:Ubiquitin / Q000378:metabolism*; D044764:Ubiquitin-Activating Enzymes / Q000235:genetics / Q000502:physiology*; D014452:Ubiquitins / Q000031:analogs & derivatives*
D016207:Cytokines; D012333:RNA, Messenger; D034741:RNA, Small Interfering; D025521:Tumor Suppressor Proteins; C471538:UBA1 protein, human; D025801:Ubiquitin; D014452:Ubiquitins; D014212:Tretinoin; C074034:ISG15 protein, human; D007372:Interferons; D044764:Ubiquitin-Activating Enzymes